Victory Capital Management’s Asensus Surgical, Inc. ASXC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
-28,417
Closed -$7.67K 2665
2023
Q3
$7.67K Buy
28,417
+3,003
+12% +$1.09K ﹤0.01% 2492
2023
Q2
$12.8K Sell
25,414
-591
-2% -$353 ﹤0.01% 2473
2023
Q1
$17.1K Sell
26,005
-323
-1% -$219 ﹤0.01% 2521
2022
Q4
$9.14K Sell
26,328
-11
-0% -$4 ﹤0.01% 2548
2022
Q3
$12K Sell
26,339
-4,886
-16% -$2.55K ﹤0.01% 2651
2022
Q2
$12K Buy
31,225
+64
+0.2% +$29 ﹤0.01% 2641
2022
Q1
$14K Sell
31,161
-889
-3% -$685 ﹤0.01% 2659
2021
Q4
$36K Sell
32,050
-988
-3% -$1.53K ﹤0.01% 2659
2021
Q3
$61K Sell
33,038
-2,237
-6% -$5.02K ﹤0.01% 2673
2021
Q2
$112K Sell
35,275
-1,001
-3% -$2.5K ﹤0.01% 2587
2021
Q1
$118K Buy
36,276
+20,878
+136% +$75.6K ﹤0.01% 2585
2020
Q4
$10K Buy
15,398
+790
+5% +$361 ﹤0.01% 2517
2020
Q3
$5K Buy
+14,608
New +$5.66K ﹤0.01% 2475
2020
Q2
Sell
-15,272
Closed -$6K 3392
2020
Q1
$6K Buy
+15,272
New +$15.9K ﹤0.01% 3462
2019
Q4
Sell
-2,559
Closed -$21K 3380
2019
Q3
$21K Buy
+2,559
New +$34.8K ﹤0.01% 3029

Other funds holding ASXC

Victory Capital Management's ASXC Position: Q4 2023 in Review

Victory Capital Management sold out of Asensus Surgical, Inc. (ASXC) in Q4 2023, closing a stake of 28,417 shares — an estimated $7.67K sold.

Victory Capital Management first reported a position in ASXC in Q3 2019 and held it in 15 quarters. The position peaked at $118K in Q1 2021. 73 funds tracked by Wall St. Rank hold ASXC as of Q4 2023.

  • Victory Capital Management reported no remaining Asensus Surgical, Inc. position as of Q4 2023 after selling out during the quarter.
  • Victory Capital Management sold 28,417 Asensus Surgical, Inc. shares in Q4 2023, an estimated $7.67K.
  • Victory Capital Management first reported a position in Asensus Surgical, Inc. in Q3 2019 and held it in 15 quarters.
  • Victory Capital Management's Asensus Surgical, Inc. position peaked at $118K in Q1 2021.
  • 73 funds tracked by Wall St. Rank held Asensus Surgical, Inc. as of Q4 2023.

Based on Victory Capital Management's 13F filing for Q4 2023, filed 5 Feb 2024.